Seeking AlphaWed, 17 Jun 2026 16:02:18 GMTRhythm Pharmaceuticals, Inc. (RYTM) Discusses Positive Interim Results from Phase 2 Setmelanotide Trial in Prader-Willi Syndrome TranscriptRYTM-5.49%
Seeking AlphaMon, 08 Jun 2026 21:28:31 GMTRhythm Pharmaceuticals, Inc. (RYTM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptRYTM-5.49%
Seeking AlphaWed, 03 Jun 2026 06:58:35 GMTRhythm Pharmaceuticals: The Rare Obesity Platform Is Becoming A Commercial EngineRYTM-5.49%
Seeking AlphaThu, 14 May 2026 03:00:45 GMTRhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 TranscriptRYTM-5.49%
BenzingaWed, 06 May 2026 18:04:59 GMTRhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 ResultsRYTM-5.49%
Seeking AlphaTue, 05 May 2026 21:31:20 GMTRhythm Pharmaceuticals, Inc. (RYTM) Q1 2026 Earnings Call TranscriptRYTM-5.49%
Zacks Investment ResearchTue, 05 May 2026 13:26:14 GMTRhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue EstimatesRYTM-5.49%
Zacks Investment ResearchWed, 29 Apr 2026 15:02:43 GMTSarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings GrowthRYTM-5.49%
Zacks Investment ResearchTue, 28 Apr 2026 15:06:43 GMTAnalysts Estimate Rhythm Pharmaceuticals, Inc. (RYTM) to Report a Decline in Earnings: What to Look Out forRYTM-5.49%
